Novavax (NVAX) Non-Current Assets (2010 - 2026)

Novavax's Non-Current Assets history runs 17 years deep, the most recent figure standing at $192.3 million for Q1 2026.

• In Q1 2026, Non-Current Assets fell 54.74% year-over-year to $192.3 million; the TTM figure through Mar 2026 stood at $1.0 billion (down 51.31% YoY), while the FY2025 annual figure was $198.2 million, down 54.06% from the prior year.
• Non-Current Assets was $192.3 million for Q1 2026 at Novavax, down from $198.2 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $653.6 million in Q4 2023 to a low of $192.3 million in Q1 2026.
• Historically, Non-Current Assets has averaged $481.8 million across 5 years, with a median of $507.5 million in 2022.
• The sharpest annual moves came in 2022 and 2025: Non-Current Assets soared 34.82% in 2022, then tumbled 66.28% in 2025.
• A 5-year view of Non-Current Assets shows it stood at $555.3 million in 2022, then gained by 17.71% to $653.6 million in 2023, then slumped by 33.98% to $431.5 million in 2024, then sank by 54.06% to $198.2 million in 2025, then fell by 2.97% to $192.3 million in 2026.
• The last three Non-Current Assets figures came in at $192.3 million (Q1 2026), $198.2 million (Q4 2025), and $205.3 million (Q3 2025), per Business Quant data.